Non-Hodgkin lymphoma, all

C3_NONHODGKIN

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C82, C83, C84, C85 Cause of death: ICD-9 — 200 Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 967[0-9]\|970[0-2] Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	1713
4. Check minimum number of events None	1713
5. Include endpoints None	1713
6. Filter based on genotype QC (FinnGen only)	1663

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF9

NAME	C3_NONHODGKIN
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C8[2-5]
COD_ICD_9	200
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	967[0-9]\|970[0-2]
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Non-Hodgkin lymphoma, all based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Mantle cell lymphoma

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1663	560	1103
Unadjusted period prevalence (%)	0.40	0.20	0.51
Median age at first event (years)	72.56	72.06	72.81

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1713: Matched controls
17130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1228.8

321.4

304

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

512.3

308.9

299

JN4AD

NOMESCO Finland

Body CT examination

12.7

307.7

453

473

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3375.5

307.7

512

JN6AD

NOMESCO Finland

CT of torso and neck

90.4

307.7

207

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

307.7

630

D70.82

ICD-10 Finland

Drug-induced neutropenia

191.0

307.7

217

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

12.7

307.7

411

417

L03AA02

ATC

filgrastim; parenteral

695.8

307.7

495

WW500

NOMESCO Finland

Blood transfusion

40.9

307.7

446

146

H02AB02

ATC

dexamethasone; systemic

66.8

307.7

432

A03FA01

ATC

metoclopramide; systemic, rectal

14.5

307.7

792

962

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

307.7

360

JN4BD

NOMESCO Finland

Extensive body CT

24.5

307.7

609

377

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

307.7

596

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1317.6

307.7

404

Z51.5

ICD-10 Finland

Palliative care

15.8

307.7

443

369

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

102.8

307.7

192

XW000

NOMESCO Finland

Bone marrow biopsy

33.9

307.7

566

246

L03AA13

ATC

pegfilgrastim; parenteral

1951.4

307.7

437

M04AA01

ATC

allopurinol; systemic

7.2

307.7

813

1898

PJA10

NOMESCO Finland

Exploration of lymph nodes

97.2

307.7

198

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

31.9

307.7

268

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

27.5

307.7

240

101

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

79.5

307.7

228

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

281.8

307.7

1146

122

A04AA01

ATC

ondansetron; systemic, rectal

38.6

307.7

409

138

1XC02, ,

NOMESCO Finland

97.3

305.6

159

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

303.4

282

WF002

NOMESCO Finland

Radical radiotherapy

153.6

283.6

141

A04AA02

ATC

granisetron; systemic, transdermal

794.2

280.7

269

ZX120

NOMESCO Finland

Intravenous

8.3

265.7

402

607

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.2

252.1

549

1203

WF049

NOMESCO Finland

Radiotherapy of metastasis

2264.6

222.8

211

N02AA05

ATC

oxycodone; systemic

5.1

213.4

603

1637

ZX112

NOMESCO Finland

Subcutaneous

39.0

210.6

130

R50.9

ICD-10 Finland

Fever, unspecified

5.3

201.3

525

1326

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2280.9

199.9

190

XX3DW

NOMESCO Finland

Time consuming IT work

8.4

177.9

252

346

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

48.7

173.1

101

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

13.6

169.8

164

132

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.3

166.8

270

430

C61

ICD-10 Finland

Malignant neoplasm of prostate

593.3

166.1

162

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

37.7

165.7

103

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

165.3

156

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

67.0

162.2

WF004

NOMESCO Finland

Palliative radiotherapy

1734.7

161.0

154

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

157.8

149

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

250.1

157.1

159

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

52.7

156.9

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

13.3

156.8

153

125

H02AB06

ATC

prednisolone; systemic

3.9

156.3

1144

5838

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

154.6

146

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

150.3

142

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

777.6

147.4

143

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

147.0

139

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

144.9

137

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

141.7

134

WZC00

NOMESCO Finland

Treatment plan or consultation

3.6

134.2

655

2525

WW300

NOMESCO Finland

Transfer of autologic stem cells

1369.7

132.1

127

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

21.4

128.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.0

120.9

133

130

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

166.9

119.0

124

D70.89

ICD-10 Finland

Neutropenic splenomegaly

23.8

116.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

7.4

113.6

174

258

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

112.8

107

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

112.8

107

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

35.2

112.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.1

111.3

262

588

WF003

NOMESCO Finland

Adjuvant radiotherapy

1105.3

107.6

104

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

106.4

101

JN4CD

NOMESCO Finland

Very extensive body CT

12.8

106.2

105

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

+∞

105.3

100

TGC00

NOMESCO Finland

Bronchial lavation

8.6

103.5

137

171

L01AA02

ATC

chlorambucil; oral

361.6

103.3

103

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

99.1

346

1046

J05AB11

ATC

valaciclovir; oral

3.7

96.0

365

1168

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

94.7

ZX108

NOMESCO Finland

Inhalation

24.9

94.5

A41.9

ICD-10 Finland

Sepsis, unspecified

5.9

93.2

177

326

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

171.2

93.2

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

91.5

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

90.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.7

88.8

148

239

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

237.3

88.3

116

Kela drug reimbursment

Prostate cancer

+∞

88.3

130

Kela drug reimbursment

Malignant tumour

+∞

87.2

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

122.8

86.9

H02AB07

ATC

prednisone; oral

3.3

86.7

398

1429

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

40.4

83.6

9700/3-C44.9

ICD-O-3

Mycosis fungoides of skin, NOS

+∞

83.0

212

Kela drug reimbursment

Gout

6.7

81.8

136

219

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

782.3

76.9

WZC30

NOMESCO Finland

Teaching

3.5

75.7

308

1019

J01MA12

ATC

levofloxacin; systemic

2.9

74.8

466

1974

ZX090

NOMESCO Finland

Other technic of radiotherapy

198.7

73.8

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

158.9

72.6

WW409

NOMESCO Finland

Other aferesis

+∞

72.4

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

70.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.9

70.0

228

649

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

69.9

953

5824

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

68.7

468

2066

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

684.3

67.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.6

67.3

133

253

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

6.6

67.2

111

177

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

67.1

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

65.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

92.6

64.4

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

118.0

63.3

A02BC02

ATC

pantoprazole; systemic

2.5

63.2

1223

8565

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

62.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.1

61.9

181

475

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

61.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

619.6

61.2

B72

ICPC

Hodgkin Lymphoma

608.8

60.1

390

Kela drug reimbursment

Ibrutinib

+∞

59.7

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

25.3

59.7

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

58.7

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

58.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

27.3

58.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

57.6

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

57.4

331

1328

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

57.1

144

337

B01AB10

ATC

tinzaparin; parenteral

3.7

56.6

196

579

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

+∞

56.6

L02AE02

ATC

leuprorelin; implant, parenteral

152.7

56.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.1

55.7

257

909

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

+∞

55.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

7.8

54.2

101

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

53.4

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

5.5

52.9

105

200

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.0

52.9

159

425

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

+∞

52.4

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

20.5

52.2

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

51.3

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

113.6

51.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.2

50.8

107

215

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

50.2

1512

Kela drug reimbursment

Ibrutinib

+∞

49.2

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

49.2

WW402

NOMESCO Finland

Leucoferesis

+∞

49.2

E83.50

ICD-10 Finland

Hypercalcemia

10.1

49.1

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

15.9

48.7

GD1AD

NOMESCO Finland

Thorax CT examination

4.0

48.3

147

396

ZX070

NOMESCO Finland

Intensity modified radiotherapy

252.0

48.3

B01AB05

ATC

enoxaparin; parenteral

2.2

48.3

566

3121

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

7.5

46.4

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

164.5

46.0

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

46.0

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

46.0

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

46.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

45.5

664

3966

A79

ICPC

Malignancy NOS

123.4

45.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

44.7

184

605

PJA12

NOMESCO Finland

Sentinel node biopsy

230.9

44.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.7

44.0

154

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

42.9

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

42.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.8

42.8

115

Kela drug reimbursment

Breast cancer

+∞

41.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

41.8

424

2185

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.7

41.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.2

41.0

112

278

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

12.8

41.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

40.7

250

1025

HA1AA

NOMESCO Finland

X-ray mammography

6.0

40.4

127

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

143.4

39.9

TAB00

NOMESCO Finland

Lumbar puncture

4.3

39.9

107

262

WW200

NOMESCO Finland

Immunization

5.4

39.8

154

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

+∞

39.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

39.6

415

2162

127

Kela drug reimbursment

Transplant complication

9.4

39.3

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

38.7

9700/3-C44.5

ICD-O-3

Mycosis fungoides of skin of trunk

+∞

38.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

38.5

196

727

H02AB09

ATC

hydrocortisone; systemic

6.1

38.4

116

A06AH03

ATC

naloxegol; oral

14.3

38.3

D69.5

ICD-10 Finland

Secondary thrombocytopenia

51.3

37.7

L02BB03

ATC

bicalutamide; oral

+∞

37.6

L01CB01

ATC

etoposide; systemic

+∞

37.6

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

37.6

L01EL01

ATC

ibrutinib; oral

+∞

37.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.6

37.2

A07AA02

ATC

nystatin; oral

3.3

37.2

147

470

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

36.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

+∞

36.6

1AA09, ,

NOMESCO Finland

+∞

36.6

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

36.6

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

36.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

8.6

36.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.5

35.6

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

35.5

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

11.1

34.7

J05AB01

ATC

aciclovir; systemic

2.2

34.7

375

1966

J01MA14

ATC

moxifloxacin; systemic

2.7

34.1

202

810

Z51.0

ICD-10 Finland

Radiotherapy session

343.8

34.0

Y77

ICPC

Malignant neoplasm prostate

122.5

33.8

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.4

33.1

201

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

333.3

33.0

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

333.3

33.0

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

119.0

32.8

JFB00

NOMESCO Finland

Partial resection of small intestine

7.3

32.7

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

32.4

L01XE27

ATC

[U] ibrutinib

+∞

32.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.1

32.1

141

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

7.0

31.9

ZXE00

NOMESCO Finland

One hour or less

1.9

31.2

632

4100

ZZR00

NOMESCO Finland

Flap of skin

12.1

30.8

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

30.3

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

30.3

A04AD12

ATC

aprepitant; systemic

+∞

30.3

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

+∞

30.3

TQW99

NOMESCO Finland

Other minor procedure on skin

3.7

29.8

273

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

296.8

28.9

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

26.6

28.4

C82.0

ICD-10 Finland

Follicular lymphoma grade I

+∞

28.2

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

28.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

28.0

103

314

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

147.4

27.7

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

27.2

A04AA55

ATC

palonosetron, combinations; systemic

+∞

27.2

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

27.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

27.2

235

1118

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.5

27.1

281

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

26.9

154

605

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

275.2

26.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

275.2

26.8

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

275.2

26.8

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.7

26.7

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

142.2

26.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

26.6

762

5410

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

26.4

192

846

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.9

26.4

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

23.6

26.1

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

+∞

26.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

26.1

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

26.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

25.9

522

3344

C90.0

ICD-10 Finland

Multiple myeloma

264.5

25.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.8

25.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.7

25.6

132

Z2446

NOMESCO Finland

Social worker

2.9

25.3

125

454

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.7

25.1

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

25.1

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

+∞

25.1

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

25.1

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

25.1

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

25.1

R4190

NOMESCO Finland

Nutritional therapy

4.8

24.9

119

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

24.7

24.4

R4110

NOMESCO Finland

Physiotherapy

1.8

24.0

446

2776

R06AE07

ATC

cetirizine; oral

1.7

24.0

601

4079

HAB40

NOMESCO Finland

Wedge excision of mammary gland

23.1

23.9

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.3

23.8

EMA10

NOMESCO Finland

Biopsy of tonsil

31.5

23.7

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

88.0

23.7

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.7

23.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

23.4

539

3570

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

23.0

9679/3-C38.3

ICD-O-3

Mediastinal large B-cell lymphoma of mediastinum, NOS

+∞

23.0

N05CF01

ATC

zopiclone; oral

1.7

22.9

589

4017

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

30.5

22.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

84.6

22.7

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

4.2

22.4

151

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

5.2

22.0

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

21.9

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

21.9

L01BC06

ATC

capecitabine; oral

+∞

21.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

21.5

261

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

21.4

562

3838

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.8

21.4

179

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

19.2

21.3

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

6.2

21.1

B03XA02

ATC

darbepoetin alfa; parenteral

4.5

21.1

119

ZXC50

NOMESCO Finland

Cryotherapy

4.0

21.0

154

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

21.0

395

2456

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

+∞

20.9

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

20.9

C84.1

ICD-10 Finland

Sézary disease

+∞

20.9

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

20.9

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

20.9

L01BB05

ATC

fludarabine; systemic

+∞

20.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

20.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

20.9

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

21.8

20.8

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

37.7

20.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

20.7

124

497

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

111.4

20.6

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

42.2

20.5

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

22.7

20.4

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.6

20.4

110

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.5

20.4

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.5

20.4

214

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.1

20.3

297

TQW80

NOMESCO Finland

Local dermatologic skincare

3.8

20.2

163

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

48.6

20.2

L57.0

ICD-10 Finland

Actinic keratosis

2.3

20.1

170

798

A41.8

ICD-10 Finland

Other specified sepsis

3.9

19.8

156

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

19.8

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

19.8

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

19.8

WW200, ,

SPAT

0.4

19.8

106

2445

J02AC03

ATC

voriconazole; systemic

74.4

19.7

XX1AD

NOMESCO Finland

Other CT-examination

106.3

19.6

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

202.2

19.6

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.9

19.6

B02.9

ICD-10 Finland

Zoster without complication

2.4

19.5

138

599

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

19.3

966

7672

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

31.7

19.3

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.2

19.1

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

26.4

19.1

Z2221

NOMESCO Finland

Medical doctor

1.7

19.1

409

2630

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.0

18.9

293

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

18.8

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

18.8

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

18.8

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

18.8

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

18.8

L02BG04

ATC

letrozole; oral

21.1

18.6

HAC20

NOMESCO Finland

Total mastectomy

101.2

18.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

192.0

18.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

192.0

18.6

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.0

18.6

Z3231

NOMESCO Finland

Registered nurse

1.7

18.5

430

2825

N02AX02

ATC

tramadol; systemic, rectal

1.6

18.4

683

5040

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.0

18.3

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.0

18.1

ED1AA

NOMESCO Finland

Mandibular X-ray examination

16.7

17.9

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.9

17.8

D07AB08

ATC

desonide; topical

2.1

17.7

188

963

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

17.7

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

17.7

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

17.7

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

17.7

9702/3-C77.8

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

17.7

Z52.89

ICD-10 Finland

Donor of other organ or tissue

+∞

17.7

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

17.7

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

17.7

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

17.7

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

+∞

17.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

96.1

17.6

TK800

NOMESCO Finland

Hemodialysis

3.9

17.4

138

L04AD01

ATC

ciclosporin; systemic

5.0

17.1

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.5

17.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

17.0

243

1381

N02AA01

ATC

morphine; systemic, rectal

4.5

16.9

C03CA01

ATC

furosemide; systemic

1.6

16.7

713

5397

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

16.7

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

16.7

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

16.7

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

16.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

16.7

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

16.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

16.7

585

4237

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

91.0

16.6

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.1

16.4

112

TPX15

NOMESCO Finland

Removal of vascular injection port

40.5

16.3

ZXD05

NOMESCO Finland

Urgent procedure

1.6

16.2

498

3490

C10AA07

ATC

rosuvastatin; oral

0.5

16.1

231

3800

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

16.1

141

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

16.9

16.1

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

16.9

16.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

48.0

16.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

15.8

256

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

15.8

15.7

9700/3-C44.7

ICD-O-3

Mycosis fungoides of skin of lower limb and hip

+∞

15.6

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

15.6

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

+∞

15.6

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

+∞

15.6

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

15.6

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

15.6

N03AX16

ATC

[U] pregabalin

1.7

15.6

362

2364

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

15.5

286

1753

L26

ICD-10 Finland

Exfoliative dermatitis

14.9

15.4

J01DB01

ATC

cefalexin; oral

1.6

15.1

1233

10635

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

15.0

438

3023

J02AC01

ATC

fluconazole; systemic

1.6

15.0

443

3066

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

6.8

14.9

J12.8

ICD-10 Finland

Other viral pneumonia

6.0

14.8

L02BA01

ATC

tamoxifen; oral

57.2

14.8

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

57.2

14.8

JMA10

NOMESCO Finland

Transabdominal total splenectomy

21.2

14.7

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

14.6

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

+∞

14.6

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

14.6

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

+∞

14.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

14.6

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

14.6

ZX131

NOMESCO Finland

Intrathecal

+∞

14.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

14.6

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

14.6

AAA10

NOMESCO Finland

Biopsy through craniotomy

80.8

14.6

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.8

14.5

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.7

14.5

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

151.2

14.5

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

36.4

14.4

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.3

14.4

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

14.4

2073

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

17.1

14.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

19.3

14.2

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

42.9

14.1

B74

ICPC

Malignant neoplasm blood other

42.9

14.1

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.3

13.9

WF099

NOMESCO Finland

Other radiotherapy

30.3

13.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.1

13.9

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.3

13.9

WX002

NOMESCO Finland

Sedation and analgesia

1.7

13.8

309

1993

TGD00

NOMESCO Finland

Needle biopsy of lung

24.0

13.8

1CX01, ,

NOMESCO Finland

75.7

13.6

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

14.8

13.6

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

13.6

C82.7

ICD-10 Finland

Other types of follicular lymphoma

+∞

13.6

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

13.6

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

13.6

372

Kela drug reimbursment

Idelalisib

+∞

13.6

1XX25, ,

NOMESCO Finland

+∞

13.6

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

13.6

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

13.6

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

+∞

13.6

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

+∞

13.6

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

13.6

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

13.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

141.1

13.5

DAB10

NOMESCO Finland

Partial excision of auricle

141.1

13.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

141.1

13.5

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.2

13.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

13.1

260

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

19.2

12.9

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

22.7

12.9

D05BB02

ATC

acitretin; oral

3.2

12.7

165

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

12.5

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.3

12.5

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

24.5

12.5

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

130.9

12.4

ZX196, ,

NOMESCO Finland

130.9

12.4

V03AF03

ATC

calcium folinate; systemic

130.9

12.4

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

12.4

175

987

EMB10

NOMESCO Finland

Tonsillectomy

3.3

12.4

142

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

37.8

12.2

L02AE03

ATC

goserelin; implant

47.0

11.9

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.2

11.8

151

UJF32

NOMESCO Finland

Coloscopy

1.5

11.8

390

2751

P20

ICPC

Memory disturbance

0.5

11.8

123

2253

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

10.6

11.8

L04AA06

ATC

mycophenolic acid; systemic

4.0

11.8

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

65.4

11.6

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.6

11.6

108

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

19.1

11.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

11.6

181

1053

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.1

11.6

G53.0

ICD-10 Finland

Postzoster neuralgia

5.7

11.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

11.5

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

11.5

3AA13, ,

NOMESCO Finland

+∞

11.5

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

11.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

11.5

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

11.5

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

11.5

9670/3-C42.1

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of bone marrow

+∞

11.5

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

11.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

11.5

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

11.5

C50.99

ICD-10 Finland

Breast, unspecified

+∞

11.5

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

11.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

11.5

9702/3-C42.1

ICD-O-3

Mature T-cell lymphoma, NOS, of bone marrow

+∞

11.5

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

11.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

11.5

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

11.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

11.5

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

11.5

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

120.8

11.4

Z51.88

ICD-10 Finland

Other specified medical care

3.3

11.4

134

A02BC01

ATC

omeprazole; systemic

1.5

11.4

453

3320

JAH01

NOMESCO Finland

Laparoscopy

3.3

11.3

130

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

11.0

473

3516

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

10.1

11.0

ZX114

NOMESCO Finland

Intramuscular

4.7

11.0

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

43.6

10.9

J01MA02

ATC

ciprofloxacin; systemic

1.4

10.9

620

4859

B01AB04

ATC

dalteparin; parenteral

2.3

10.9

341

R50.8

ICD-10 Finland

Other specified fever

12.0

10.8

A07AA09

ATC

vancomycin; oral

3.7

10.8

A98

ICPC

Health maint/preventive medicine

0.7

10.8

1197

13217

WX882

NOMESCO Finland

High dependency care

2.8

10.8

187

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.9

10.8

134

Kela drug reimbursment

General erythroderma

9.6

10.8

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.5

10.7

6BA02, ,

NOMESCO Finland

28.2

10.7

N06DX01

ATC

memantine; oral

0.4

10.7

1420

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.7

10.6

206

E0000UV, ,

ATC

1.4

10.5

569

4411

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.3

10.5

821

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

110.7

10.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

10.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

10.4

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

10.4

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

10.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

10.4

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

10.4

9670/3-C80.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site

+∞

10.4

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

10.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

L01XX47

ATC

[U] idelalisib

+∞

10.4

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

10.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

10.4

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

+∞

10.4

9700/3-C44.6

ICD-O-3

Mycosis fungoides of skin of upper limb and shoulder

+∞

10.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

10.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

12.1

10.3

A05AA02

ATC

ursodeoxycholic acid; oral

4.3

10.3

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

10.7

10.3

L01AA01

ATC

cyclophosphamide; systemic

9.6

10.3

N03AX14

ATC

levetiracetam; systemic

2.8

10.2

176

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.1

10.2

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.0

10.1

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

10.0

119

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

10.0

111

1999

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.9

9.9

157

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

16.8

9.9

L41.8

ICD-10 Finland

Other parapsoriasis

26.2

9.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

9.8

201

1263

D02AX

ATC

Other emollients and protectives

2.9

9.6

149

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.0

9.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

9.5

526

4082

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

9.5

108

568

4701

FHL

Neck lymph node removal

30.2

9.4

120

Kela drug reimbursment

Hypogammaglobulinaemia

30.2

9.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

9.4

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

9.4

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

+∞

9.4

9705/3-C77.8

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions

+∞

9.4

9680/3-C62.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of testis, NOS

+∞

9.4

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

9.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

9.4

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

+∞

9.4

9673/3-C80.9

ICD-O-3

Mantle cell lymphoma of unknown primary site

+∞

9.4

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

9.4

L02BG03

ATC

anastrozole; oral

+∞

9.4

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

9.4

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

+∞

9.4

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

21.8

9.4

JAL00

NOMESCO Finland

Biopsy of peritoneum

13.7

9.2

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

9.1

297

2080

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.8

9.1

UKC02

NOMESCO Finland

Cystoscopy

1.5

9.0

278

1921

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

36.9

9.0

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.1

9.0

122

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

9.0

149

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

8.9

363

2656

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

24.1

8.9

ZXC95

NOMESCO Finland

Use of surgical navigator

4.4

8.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

8.8

249

1687

J35.1

ICD-10 Finland

Hypertrophy of tonsils

6.8

8.8

WX402

NOMESCO Finland

General anaesthesia

1.6

8.8

203

1311

XQ848

NOMESCO Finland

Dermatological photography

2.8

8.7

152

5702

FHL

Local lymph node removal (eg armpit, groin)

50.2

8.7

L41.9

ICD-10 Finland

Parapsoriasis, unspecified

50.2

8.7

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

8.7

493

C10AX09

ATC

ezetimibe; oral

0.5

8.6

107

1868

GEA00

NOMESCO Finland

Mediastinoscopy

11.6

8.6

L04AA01

ATC

[U] ciclosporin

4.1

8.5

A06AD11

ATC

lactulose; oral

1.5

8.5

291

2055

B73

ICPC

Leukaemia

90.5

8.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

90.5

8.4

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

90.5

8.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

90.5

8.4

L41.4

ICD-10 Finland

Large plaque parapsoriasis

90.5

8.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

90.5

8.4

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

8.4

1148

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.3

8.4

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.8

8.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

8.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

8.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

8.3

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

8.3

9591/3-C80.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site

+∞

8.3

9591/3-C16.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS

+∞

8.3

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

8.3

3AX16, ,

NOMESCO Finland

+∞

8.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

8.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

8.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

8.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

8.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

8.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

8.3

ZXA00

NOMESCO Finland

Right side

1.4

8.2

428

3270

N06DA02

ATC

donepezil; oral

0.4

8.1

1065

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

33.5

8.1

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

33.5

8.1

ZZA50

NOMESCO Finland

Full thickness skin graft

22.1

8.0

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

22.1

8.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

8.0

314

2279

L08

ICPC

Shoulder symptom/complaint

0.6

7.9

138

2203

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.3

7.9

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

7.9

410

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

7.9

474

JFB30

NOMESCO Finland

Right hemicolectomy

7.8

7.9

N05AX08

ATC

risperidone; systemic

0.5

7.9

1174

E000003, ,

ATC

2.2

7.8

298

WZC00, ,

SPAT

0.4

7.8

869

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

7.8

213

3064

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

45.2

7.7

N74

ICPC

Malignant neoplasm nervous system

45.2

7.7

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

15.1

7.7

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.6

7.7

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.5

7.7

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.7

269

1908

D07AD01

ATC

clobetasol; topical

1.5

7.6

219

1488

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

7.6

314

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

7.6

308

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

11.9

7.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

25.1

7.6

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

25.1

7.6

RS221, ,

NOMESCO Finland

3.5

7.6

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

4.1

7.5

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

7.5

326

2408

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.5

119

696

EB1VA, ,

NOMESCO Finland

0.4

7.5

882

TGA30

NOMESCO Finland

Thoracocentesis

4.4

7.4

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

80.4

7.4

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

80.4

7.4

C50

ICD-10 Finland

Malignant neoplasm of breast

80.4

7.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

80.4

7.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

80.4

7.4

OAB42, ,

SPAT

0.4

7.4

877

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

7.4

471

J01FF01

ATC

clindamycin; systemic

1.4

7.4

370

2805

D07AA02

ATC

hydrocortisone; topical

1.6

7.3

179

1172

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

8.4

7.3

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.4

7.3

9702/3-C80.9

ICD-O-3

Mature T-cell lymphoma, NOS, of unknown primary site

+∞

7.3

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

7.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

7.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

7.3

9680/3-C34.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lung, NOS

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

+∞

7.3

9591/3-C34.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

+∞

7.3

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

7.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

7.3

9717/3-C17.9

ICD-O-3

Intestinal T-cell lymphoma of small intestine, NOS

+∞

7.3

9701/3-C44.9

ICD-O-3

Sezary syndrome of skin, NOS

+∞

7.3

JAH21

NOMESCO Finland

Staging laparoscopy

+∞

7.3

C84.42

ICD-10 Finland

Peripheral T-cell lymphoma, both medium and large cell type

+∞

7.3

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

7.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

7.3

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

7.3

9670/3-C77.3

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm

+∞

7.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

7.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

1XX32, ,

NOMESCO Finland

+∞

7.3

3AF07, ,

NOMESCO Finland

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

7.3

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

7.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

7.3

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

7.3

L02BX02

ATC

degarelix; parenteral

+∞

7.3

9670/3-C77.4

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

9680/3-C49.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip

+∞

7.3

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

7.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

7.3

9680/3-C49.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS

+∞

7.3

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

7.3

A02BA02

ATC

ranitidine; systemic

1.4

7.3

324

2404

ZX121

NOMESCO Finland

Central venous catheter

15.8

7.2

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

15.8

7.2

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

7.2

460

C10AB05

ATC

fenofibrate; oral

2.7

7.2

139

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

30.1

7.1

L03AB05

ATC

interferon alfa-2b; parenteral

20.1

7.1

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

7.1

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

7.1

187

1247

KA3EB

NOMESCO Finland

Antegrade pyelography

12.1

7.1

B29

ICPC

Lymph/immune mech sympt/complt other

12.1

7.1

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

7.0

153

2319

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

10.1

7.0

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

10.1

7.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.6

7.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

7.0

366

WVA20

NOMESCO Finland

Medicine administration

2.7

6.9

136

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

13.8

6.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.6

6.9

L13

ICPC

Hip symptom/complaint

0.6

6.8

125

1972

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.7

6.8

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

9.3

6.8

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

9.3

6.8

C10AA05

ATC

atorvastatin; oral

0.7

6.8

508

6171

TDA90, ,

SPAT

0.3

6.8

523

X76

ICPC

Malignant neoplasm breast female

40.2

6.8

KAC10

NOMESCO Finland

Total nephrectomy with capsule

40.2

6.8

CAA30

NOMESCO Finland

Biopsy of orbit

40.2

6.8

D73.1

ICD-10 Finland

Hypersplenism

40.2

6.8

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

40.2

6.8

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

40.2

6.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

6.7

316

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

3.9

6.7

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.7

6.7

127

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

22.6

6.7

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

22.6

6.7

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

22.6

6.7

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

22.6

6.7

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

6.6

697

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

6.4

6.6

WX892

NOMESCO Finland

Monitored bed care

1.7

6.6

119

723

E000001, ,

ATC

1.4

6.6

263

1912

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

10.1

6.5

SPAT1088

SPAT

Blood transfusion

6.9

6.5

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

6.5

348

AXX01, ,

SPAT

0.2

6.5

322

JAH00

NOMESCO Finland

Laparotomy

2.5

6.5

159

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.7

6.5

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.9

6.4

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

70.1

6.4

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

70.1

6.4

1AA01, ,

NOMESCO Finland

70.1

6.4

L02BG06

ATC

exemestane; oral

70.1

6.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

70.1

6.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

70.1

6.4

GDC00

NOMESCO Finland

Lobectomy of lung

70.1

6.4

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

6.4

275

3650

D07AC01

ATC

betamethasone; topical

1.3

6.4

508

4127

ENA10

NOMESCO Finland

Biopsy of pharynx

14.4

6.4

L15

ICPC

Knee symptom/complaint

0.6

6.4

162

2376

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

6.4

282

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

6.4

296

NG1AA, ,

SPAT

0.2

6.3

319

GD6AD

NOMESCO Finland

CT of chest and neck

11.1

6.3

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.1

6.3

K65.0

ICD-10 Finland

Acute peritonitis

3.3

6.3

S77

ICPC

Malignant neoplasm of skin

18.1

6.3

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

6.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

6.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

6.3

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

+∞

6.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

6.3

U77

ICPC

Malignant neopl urinary tract other

+∞

6.3

L02BB04

ATC

enzalutamide; oral

+∞

6.3

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

+∞

6.3

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

6.3

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

6.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.3

C16.00

ICD-10 Finland

Cardia

+∞

6.3

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

6.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

6.3

9591/3-C42.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of bone marrow

+∞

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

6.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

6.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

6.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

6.3

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.3

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

6.3

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

6.3

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

6.3

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

3.0

6.2

C10AA01

ATC

simvastatin; oral

0.8

6.2

607

7140

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.0

6.2

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.9

6.2

D07AC13

ATC

mometasone; topical

1.4

6.2

394

3097

ZYC01, ,

SPAT

0.4

6.2

729

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

6.1

341

4344

K12.10

ICD-10 Finland

Stomatitis NOS

7.7

6.1

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

6.1

348

4416

ZXA05

NOMESCO Finland

Left side

1.4

6.1

376

2940

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

8.6

6.1

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

8.6

6.1

J01CA04

ATC

amoxicillin; systemic

1.3

6.0

1129

10245

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

182

47.24

308.20

3.4

1.5

0.20

0.22

e9/l

0.28

154

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1040

1368

17.81

307.65

9.6

2.5

336.81

236.55

u/l

8.97

1018

1260

(3011412) CD3 cells [#/volume] in Blood

284

60.59

307.65

2.9

1.9

1.11

1.23

e9/l

0.41

252

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

713

892

12.98

307.65

1.6

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

65.62

307.65

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

770

1089

12.03

307.65

1.7

1.5

—

(4035726) Immunohistochemistry procedure

638

299

33.41

307.65

1.9

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

282

306.69

307.65

1.4

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

372

167

28.18

307.65

6.0

5.1

3813.07

429.84

iu/ml

0.51

(3017143) Hepatitis C virus Ab [Presence] in Serum

698

843

13.29

307.65

1.6

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

656

493

20.94

307.65

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

413

173

31.14

307.65

1.9

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

324

116

34.21

307.65

3.1

2.4

23960.97

381.29

u/ml

0.92

(40768795) Lymph node Pathology biopsy report

360

267.84

307.65

1.5

1.0

—

(3045142) Bone marrow Pathology biopsy report

396

65.73

307.65

1.8

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

533

735

10.08

307.65

4.2

2.0

8.47

11.00

g/l

19.41

508

671

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

193

49.31

307.65

3.2

1.5

575.22

416.97

e6/l

1.58

155

(3017181) Myelocytes/100 leukocytes in Blood

488

880

7.36

274.75

6.9

3.6

0.94

0.80

0.63

408

247

(3028026) IgM [Mass/volume] in Serum or Plasma

402

591

8.58

272.20

3.7

1.3

2.62

1.14

g/l

5.13

375

540

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

240

171

16.16

268.68

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

222

138

18.33

266.79

5.3

3.1

1.68

1.63

0.04

212

115

(40765096) Chromosome analysis panel by Banding

131

88.57

248.80

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

259

249

12.08

241.24

2.7

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

264

262

11.73

240.66

2.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

207

146

15.99

232.35

1.4

1.3

137.68

111.58

u/ml

0.62

(3012095) Magnesium [Moles/volume] in Serum or Plasma

671

1879

5.23

230.93

8.2

2.5

0.80

0.82

mmol/l

6.48

651

1709

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

164

24.74

227.86

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

218

181

13.65

222.56

2.7

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

423

843

6.34

211.85

7.1

3.7

0.15

0.07

1.83

339

207

(3002179) Metamyelocytes/100 leukocytes in Blood

412

803

6.44

211.09

6.5

3.6

0.64

0.67

0.11

326

213

(3026493) Urate [Moles/volume] in Serum or Plasma

913

3478

4.48

207.16

7.6

2.6

1063.52

7743.63

umol/l

8.73

882

2946

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

141

28.36

206.81

4.4

2.2

31.38

46.37

6.32

112

(21494814) CD8 cells/100 lymphocytes in Specimen

112

66.51

203.81

2.0

2.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

107

81.45

200.90

2.1

3.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

598

1720

4.81

194.92

4.2

2.0

1.87

1.75

1.59

559

1485

(40760892) CBC W Ordered Manual Differential panel - Blood

1150

5375

4.47

192.21

15.3

5.5

—

(3022096) Basophils/100 leukocytes in Blood

1131

5299

4.34

186.45

12.5

5.3

0.60

0.65

2.81

1106

4851

(3003458) Phosphate [Moles/volume] in Serum or Plasma

585

1710

4.68

185.73

7.7

4.9

1.06

1.03

mmol/l

1.59

565

1557

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

190

171

12.37

183.73

2.6

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

190

171

12.37

183.73

2.6

1.4

—

(3019069) Monocytes/100 leukocytes in Blood

1142

5484

4.25

179.33

13.4

5.6

9.65

8.91

8.30

1119

5032

(3006504) Eosinophils/100 leukocytes in Blood

1136

5463

4.20

177.33

12.8

5.3

2.37

2.98

11.16

1112

5005

(3023520) Reticulocytes [#/volume] in Blood

485

1273

4.92

175.32

4.2

2.1

70.99

67.34

e9/l

1.21

393

982

(3002030) Lymphocytes/100 leukocytes in Blood

1144

5586

4.15

173.23

13.2

5.5

25.30

25.92

0.73

1120

5148

(3000060) B lymphocytes [#/volume] in Blood

80.03

170.40

2.2

1.9

309.49

196.00

e6/l

—

(3023368) Bacteria identified in Blood by Culture

909

3835

3.92

170.12

9.9

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

191

195

10.90

169.38

2.0

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

1119

5530

3.95

162.89

11.8

5.3

57.95

58.80

1.09

1097

5100

(3001604) Monocytes [#/volume] in Blood

1151

5846

3.95

159.59

11.4

5.1

0.64

0.63

e9/l

0.91

1046

4970

(3006315) Basophils [#/volume] in Blood

1152

5869

3.94

158.64

11.4

5.1

0.03

0.04

e9/l

11.60

1048

4995

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

106

28.91

157.16

5.2

2.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

220

301

8.24

155.21

1.7

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

162

11.39

154.74

1.3

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

188

213

9.79

154.26

1.4

1.2

—

(3013115) Eosinophils [#/volume] in Blood

1166

6061

3.89

154.02

12.5

5.3

0.16

0.21

e9/l

8.99

1070

5221

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

156

11.60

154.00

1.9

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

1156

5978

3.87

153.85

11.7

5.2

1.78

1.80

e9/l

0.09

1064

5185

(3025159) Blasts/100 leukocytes in Blood

353

798

5.31

150.89

6.8

3.8

0.15

0.04

1.57

267

168

(3008757) Leukocyte morphology finding [Identifier] in Blood

138

106

14.07

146.59

6.8

3.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

160

156

11.21

146.13

2.0

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

140

111

13.65

145.95

2.9

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

396

1013

4.78

145.63

3.1

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

123

16.70

144.09

1.4

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1196

6497

3.79

143.58

31.9

5.9

3.83

4.51

e9/l

19.19

1120

5558

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

133

101

14.19

142.17

2.9

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

145

11.32

139.25

2.0

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1129

6036

3.55

136.20

18.9

3.7

11.16

12.63

umol/l

3.42

1109

5634

(3024561) Albumin [Mass/volume] in Serum or Plasma

1049

5406

3.43

133.46

10.9

3.7

31.78

34.95

g/l

49.45

1014

4916

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

362

920

4.72

133.44

2.6

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

149

152

10.64

131.66

1.3

1.2

294.82

258.01

u/ml

0.44

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

244

443

6.26

131.59

2.5

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

156

171

9.94

130.84

2.0

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

412

1176

4.30

130.43

3.7

1.6

63.68

66.46

g/l

6.48

398

1041

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

135

124

11.73

128.11

2.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

188

268

7.76

127.43

1.5

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

121

100

12.94

122.76

5.5

3.0

57.15

58.64

0.23

116

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

100

17.07

119.03

2.8

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

36.78

118.42

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

599

2359

3.37

115.92

3.2

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

166

240

7.55

110.82

1.6

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

39.30

110.77

4.9

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

16.52

110.17

1.4

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

258

577

5.09

110.02

3.0

1.7

2.82

1.65

ug/l

0.49

243

498

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

23.61

109.10

1.6

2.3

5022.50

6647.80

u/ml

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

12.92

107.85

3.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

12.92

107.85

3.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

12.92

107.85

3.4

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

123

128

10.28

106.86

1.8

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

123

128

10.28

106.86

1.8

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

24.05

105.75

1.3

1.4

—

(3000012) Reticulocyte production index

149

203

7.94

104.68

2.8

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

271

663

4.67

103.38

2.2

1.3

3.61

2.87

ug/l

0.96

209

492

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

57.86

99.31

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

27.19

99.06

4.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

27.19

99.06

4.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

27.19

99.06

4.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

735

3510

2.92

98.51

5.6

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

213

444

5.34

98.14

3.2

1.5

19.64

1.80

ratio

0.83

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

216

458

5.25

97.59

3.2

1.5

42.52

35.20

mg/l

0.64

174

374

(3034860) Kappa light chains.free [Mass/volume] in Serum

216

459

5.24

97.34

3.2

1.5

66.60

47.73

mg/l

1.68

176

375

(40768804) Tissue Pathology biopsy report

710

3388

2.87

94.44

2.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

132.65

94.07

1.7

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

446

1658

3.28

92.27

2.7

1.8

—

(21494434) Karyotype in Bone marrow

102

101

10.68

91.64

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

791

4050

2.77

91.09

8.7

2.0

2.33

2.35

mmol/l

2.43

745

3339

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

156

266

6.35

88.79

3.3

2.4

3.74

3.48

g/l

0.87

151

248

(3042936) Bacteria identified in Isolate by Culture

456

1755

3.18

88.60

2.1

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

438

1660

3.20

87.22

2.6

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1068

6470

2.73

86.28

15.3

5.6

1.23

1.21

mmol/l

4.96

920

5481

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

131

8.90

86.12

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

253

673

4.24

85.94

1.9

1.6

1.63

1.50

g/l

1.10

201

570

(3007164) IgA [Mass/volume] in Serum or Plasma

459

1842

3.04

82.24

2.3

1.3

2.28

2.79

g/l

2.53

386

1038

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

586

2700

2.78

81.03

5.0

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

16.30

80.69

4.1

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

16.30

80.69

4.1

1.1

—

(3042631) Mycobacterium sp identified in Specimen

117

164

7.58

79.90

2.2

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

181

395

5.01

78.63

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

974

5846

2.54

76.82

13.3

5.3

1.22

1.21

mmol/l

2.06

945

5187

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

342

1200

3.31

76.58

5.2

2.3

8.10

9.29

umol/l

0.54

314

1034

(3008536) Aspergillus sp Ab [Presence] in Serum

33.60

76.41

2.9

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

120

8.69

76.34

1.4

1.1

—

(3018418) pH of Serum or Plasma

718

3756

2.57

75.75

10.1

3.2

7.41

7.40

2.31

167

646

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

11.62

75.65

2.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

899

5232

2.51

75.29

5.5

2.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

171

7.14

74.43

6.3

6.5

12.14

12.46

mg/l

0.25

106

154

(40760888) Immunoglobulin light chains.free panel - Serum

162

338

5.19

74.06

3.2

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

12.91

73.85

2.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

12.69

73.08

2.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

41.03

72.37

1.6

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

580

4.07

70.34

3.6

1.4

3.90

3.76

g/l

0.19

207

500

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

580

4.07

70.34

3.6

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

580

4.07

70.34

3.6

1.4

7.04

7.54

g/l

3.63

207

500

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

14.18

68.40

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

517

2411

2.64

67.92

7.4

2.2

2.50

2.45

mmol/l

10.46

492

2040

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

190

486

4.27

67.44

3.6

1.5

2.31

0.47

g/l

4.10

169

405

(40758558) Short blood count panel - Blood

559

2727

2.56

66.69

23.1

4.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

8.88

63.14

2.4

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

549

3.95

62.83

3.3

1.4

10.33

10.46

g/l

0.10

190

468

(3018677) aPTT in Platelet poor plasma by Coagulation assay

464

2122

2.63

62.76

3.4

1.9

29.53

30.22

1.17

455

2050

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

11.83

62.27

1.2

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

540

3.95

61.97

3.8

1.4

3.16

3.01

g/l

1.10

188

461

(3033658) Prothrombin time (PT) actual/Normal

569

2903

2.44

60.64

6.7

3.6

84.22

81.93

1.41

557

2817

(3002256) Pathology report gross observation

237

774

3.39

58.73

1.4

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

167

431

4.19

58.37

3.2

1.4

0.07

0.02

g/l

0.66

159

384

(3020779) Urea [Moles/volume] in Serum or Plasma

313

1210

2.94

58.16

7.4

6.2

11.44

11.62

mmol/l

0.14

305

1131

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

146

349

4.48

56.36

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

161

415

4.18

56.32

1.9

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

104

186

5.89

56.05

6.0

3.1

55.13

59.55

1.87

104

186

(3000494) Fungus identified in Specimen by Culture

328

1329

2.82

55.68

2.0

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

161

6.26

55.23

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

167

461

3.91

53.10

3.1

2.8

0.39

0.34

u/ml

0.96

102

281

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

152

397

4.10

52.16

3.3

1.4

0.00

g/l

-0.00

146

357

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

119

7.00

51.60

3.7

2.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

153

405

4.05

51.54

3.3

1.4

0.00

g/l

-0.00

146

359

(3000991) Gas panel - Venous blood

285

1121

2.85

50.86

8.8

7.4

—

(40768443) Skin Pathology biopsy report

162

456

3.82

50.03

1.8

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

141

6.21

48.24

1.4

1.2

148.30

189.21

miu/ml

0.22

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

116

263

4.66

47.74

1.8

1.4

143.13

663.49

e6/l

0.71

224

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

116

263

4.66

47.74

1.8

1.3

81.80

38.05

e6/l

0.41

219

(3002582) Erythrocytes [#/volume] in Urine

663

3907

2.14

47.59

4.0

3.2

42.32

82.70

e6/l

1.27

537

3022

(3044290) Cell count panel - Cerebral spinal fluid

105

223

4.95

46.73

1.8

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

110

243

4.77

46.71

1.8

1.7

26.10

32.97

u/ml

0.13

195

(3021589) Normoblasts [#/volume] in Blood

802

5119

2.07

46.09

21.6

8.8

0.00

e9/l

1.48

679

4132

(3002032) Base excess in Venous blood by calculation

319

1396

2.58

45.81

4.7

3.3

1.77

2.06

mmol/l

0.54

280

1152

(3012544) pH of Venous blood

327

1450

2.55

45.68

4.6

3.3

—

7.37

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

319

1402

2.57

45.37

4.7

3.2

5.70

5.84

kpa

1.54

310

1345

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

158

467

3.63

45.33

3.3

1.4

34.82

37.39

g/l

4.45

150

389

(3028433) Virus identified in Specimen by Culture

12.13

44.67

1.4

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

605

3531

2.10

43.74

3.9

3.1

0.55

0.46

e6/l

0.27

486

2708

(3022217) INR in Platelet poor plasma by Coagulation assay

967

6704

2.02

43.09

17.6

20.0

1.24

1.42

inr

7.17

265

1871

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

+∞

42.89

1.3

0.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

9.36

42.29

1.7

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

241

953

2.78

42.15

2.0

1.9

0.18

0.19

g/l

1.38

216

855

(3003694) ABO and Rh group [Type] in Blood

507

2802

2.15

41.98

1.7

1.3

—

(36304419) Bacteria [Presence] in Urine

582

3395

2.08

41.75

3.8

3.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

13.28

40.93

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

9.17

40.84

1.7

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1224

9333

2.09

40.61

22.8

5.2

89.50

77.24

u/l

12.64

1198

8552

(3009343) pH of Capillary blood

233

923

2.76

40.54

5.5

3.6

7.44

7.41

1.85

112

(3018095) Leukocytes [#/volume] in Urine

709

4479

1.99

40.44

4.6

3.6

55.92

123.84

e6/l

3.05

549

3230

(3014148) Varicella zoster virus Ab [Titer] in Serum

7.24

39.55

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

225

887

2.77

39.47

5.5

3.5

2.39

1.89

mmol/l

1.21

188

627

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

108

271

4.19

38.97

1.5

1.9

11.33

12.48

mg/l

0.60

248

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

147

457

3.42

38.92

1.5

1.8

40.02

38.54

u/l

0.30

133

373

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

164

5.13

38.05

1.1

1.0

—

(3026782) Osmolality of Urine

473

2642

2.09

37.43

3.2

2.8

534.44

545.49

mosm/kgh2o

0.57

427

2225

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

103

6.31

37.10

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

105

6.19

36.40

1.7

1.2

—

(3024471) HLA-A [Type]

14.00

35.71

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

131

5.45

34.82

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

263

1186

2.44

34.79

7.9

6.3

1.92

1.50

mmol/l

2.38

255

1146

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

9.95

33.95

1.4

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

349

1797

2.18

33.71

2.4

2.5

23.37

22.53

0.38

317

1503

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

8.62

33.58

2.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

8.62

33.58

2.6

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

8.76

33.22

3.7

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

126

5.41

33.10

1.8

1.7

20.66

31.17

u/ml

0.47

115

(3036481) Cortisol [Moles/volume] in Serum or Plasma

226

971

2.53

33.10

2.1

1.7

375.85

370.51

nmol/l

0.13

213

867

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

119

5.55

33.03

1.5

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1032

7697

1.86

32.94

9.0

4.6

6.74

6.93

mmol/l

2.71

999

7206

(3000850) Epithelial cells [#/volume] in Urine

476

2773

1.99

32.89

3.3

2.5

3.84

4.36

e6/l

0.76

439

2469

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

138

5.17

32.86

3.2

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

186

4.52

32.74

1.7

1.5

29.90

26.62

g/l

1.45

164

(3005988) Vibrio sp identified in Specimen by Organism specific culture

140

5.09

32.33

3.2

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

140

5.09

32.33

3.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

205

857

2.58

31.73

1.9

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

257

3.90

31.67

2.8

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.62

31.63

2.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

144

4.95

31.30

3.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

144

4.95

31.30

3.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

104

297

3.66

31.27

2.2

2.7

1.59

1.73

mg/l

0.83

255

(3004789) Transferrin [Mass/volume] in Serum or Plasma

359

1921

2.10

31.15

2.4

2.5

2.02

2.26

g/l

11.66

340

1760

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

322

3.55

31.15

1.5

1.6

0.06

7.98

iu/ml

0.50

(3025941) Bacteria identified in Stool by Culture

158

584

2.88

31.06

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

142

4.95

30.82

3.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

379

2091

2.04

30.18

2.4

11.81

12.62

umol/l

1.18

360

1913

(40768806) Pleura Pathology biopsy report

126

5.15

30.00

1.6

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.52

29.97

2.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1076

8290

1.80

29.16

5.9

4.6

795.13

2872.70

e6/l

1.06

152

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

365

2010

2.04

29.11

3.3

2.9

2.66

2.26

e6/l

0.18

209

1125

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

553

3506

1.85

28.94

2.2

3.73

2.97

mg/l

5.75

481

2945

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

27.72

28.04

1.8

1.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1157

9181

1.80

27.58

6.9

4.1

21.31

13.25

mm/h

28.02

1119

8351

(3012441) Differential panel - Pleural fluid

136

4.77

27.46

1.7

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

41.97

26.82

1.2

2.8

—

(3023419) Bacteria identified in Sputum by Culture

240

3.72

26.73

2.0

2.4

—

(1616796) Gas panel - Central venous blood

300

3.40

26.49

3.3

4.0

—

(3022313) Gas panel - Capillary blood

164

674

2.58

26.15

6.4

3.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

283

1472

2.11

26.09

2.0

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

163

4.24

25.16

1.7

1.5

1916.19

1463.76

e6/l

0.54

113

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

7.48

25.07

1.7

1.2

61.90

54.50

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

147

4.41

24.96

1.7

1.5

61202.17

67977.29

e6/l

0.04

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

371

2155

1.92

24.96

3.3

2.7

1.41

e6/l

0.01

214

1265

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

419

2545

1.86

24.49

2.4

1.6

2.01

1.46

mg/l

1.73

359

1971

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

963

11722

0.59

23.92

5.6

6.6

41.01

41.18

mmol/mol

0.22

863

10680

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

6.85

23.83

2.3

7.2

—

70.00

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

577

3878

1.74

23.83

3.0

2.3

54.96

60.67

u/l

0.47

543

3544

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

145

587

2.61

23.81

4.4

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

262

1368

2.08

23.77

6.1

3.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1034

12341

0.59

23.39

4.6

5.5

2.54

mmol/l

0.10

907

11169

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

980

11854

0.60

23.37

4.1

4.8

1.28

1.41

mmol/l

15.93

861

10694

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

238

3.52

23.33

1.5

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

5.41

22.84

1.5

1.2

2.95

2.03

mmol/l

1.11

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

26.27

22.68

1.4

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

135

549

2.58

21.94

7.2

4.0

25.80

24.71

mmol/l

3.66

129

496

(3003396) Base excess in Arterial blood by calculation

292

1631

1.95

21.81

9.8

6.8

1.36

1.32

mmol/l

0.04

228

1263

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

187

884

2.25

21.76

2.4

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

20.35

21.72

1.1

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

522

3485

1.72

21.68

6.1

2.6

39.52

37.64

u/l

0.22

500

3294

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

250

3.35

21.62

1.1

1.3

—

(3048879) Bone marrow aspiration report

8.83

21.57

2.3

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1003

11986

0.61

21.56

4.5

4.8

4.34

4.39

mmol/l

0.87

898

10903

(3027801) Oxygen [Partial pressure] in Arterial blood

291

1632

1.94

21.45

9.5

6.7

11.46

11.22

kpa

0.34

274

1547

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

291

1632

1.94

21.45

9.5

6.8

4.90

5.07

kpa

1.99

272

1546

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

5.96

21.39

1.2

1.6

109.93

6143.87

u/l

0.48

(3024980) IgG subclass 4 [Mass/volume] in Serum

150

4.04

20.92

1.4

1.5

0.75

1.01

g/l

0.47

119

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

198

979

2.16

20.58

2.4

2.1

35.48

32.41

u/l

0.61

168

807

(3023410) Appearance of Cerebral spinal fluid

111

4.51

20.17

1.7

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

4.84

20.16

1.5

1.2

2.45

3.02

g/l

0.93

(3024139) IgG subclass 3 [Mass/volume] in Serum

4.84

20.16

1.5

1.2

0.28

0.41

g/l

1.33

(3027135) IgG subclass 1 [Mass/volume] in Serum

4.84

20.16

1.5

1.2

5.40

7.22

g/l

1.86

(3001122) Ferritin [Mass/volume] in Serum or Plasma

663

4791

1.63

19.91

3.4

2.8

661.87

147.38

ug/l

13.89

613

4333

(3036782) Glucose [Moles/volume] in Pleural fluid

125

4.26

19.86

1.5

1.3

5.84

7.28

mmol/l

2.20

117

(21494890) Protein electrophoresis panel - 24 hour Urine

123

4.24

19.40

2.4

1.2

—

(3016502) Oxygen saturation in Arterial blood

262

1466

1.93

19.31

10.4

7.1

95.07

94.96

0.09

251

1405

(4062490) Immunoglobulin typing, IgG

4.73

19.20

1.5

1.2

—

(3026008) Bacteria identified in Urine by Culture

583

4112

1.63

19.13

3.6

3.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.76

18.55

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.86

18.52

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

199

1031

2.05

18.22

12.9

2.9

1.23

1.22

mmol/l

1.06

194

863

(3045788) Cell count panel - Pleural fluid

134

3.97

18.12

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.48

18.11

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

20.29

17.75

1.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

203

3.34

17.74

1.1

—

(3024932) HLA-DR beta [Type]

13.25

17.45

1.5

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

14.03

17.29

2.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

5.83

17.14

1.3

1.1

2282.75

48.68

ng/l

1.00

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

327

2.78

17.08

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

327

2.78

17.08

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

124

550

2.35

16.69

2.8

1.6

—

(3021901) Oxygen saturation in Capillary blood

292

2.86

16.63

3.1

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

143

690

2.17

15.73

14.3

10.3

—

(3019060) Gas panel - Arterial blood

186

994

1.98

15.55

7.0

4.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

5.79

15.41

1.1

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

228

1309

1.86

15.35

11.6

7.4

109.35

121.65

g/l

15.17

220

1282

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

188

3244

0.53

15.29

2.0

1.6

1.60

1.33

mmol/l

3.34

162

2680

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

168

3.35

14.98

1.1

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.56

14.79

1.6

1.4

59.41

63.67

0.20

(3023183) Ammonium ion [Moles/volume] in Plasma

271

2.81

14.78

2.4

2.6

35.82

33.48

umol/l

0.32

244

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

419

2872

1.61

14.78

4.1

4.2

352.63

510.38

ng/l

0.40

377

2491

(3047189) Immunofixation for 24 hour Urine

5.35

14.21

1.5

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

12.06

14.08

1.1

1.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1033

8641

1.49

14.07

5.5

4.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

337

2.57

14.05

1.5

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

340

2.55

13.80

1.5

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

989

11472

0.67

13.78

4.5

4.3

1.38

1.28

mmol/l

3.29

879

10239

(3024354) Oxygen [Partial pressure] in Venous blood

203

1164

1.84

13.67

3.9

2.7

4.64

4.46

kpa

0.47

196

1111

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.16

13.65

1.3

1.1

1.73

1.14

u/l

1.17

(42529406) Shigella sp [Presence] in Stool by Culture

342

2.53

13.64

1.5

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

12.15

13.59

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

302

2.62

13.49

2.9

2.5

14.28

16.41

5.30

161

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

16.34

13.46

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.78

13.22

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

627

4798

1.48

13.07

3.8

3.2

2651.92

1854.54

ng/l

1.68

567

4134

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

4.74

12.85

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

149

3.29

12.78

2.9

3.9

—

(3019225) pH of Specimen

220

1319

1.77

12.75

10.6

3.6

—

(3012501) Base excess in Blood by calculation

295

2.58

12.56

4.7

2.94

2.68

mmol/l

0.37

194

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

307

2.54

12.56

1.4

1.5

0.21

0.23

g/l

1.05

293

(3036048) Francisella tularensis Ab [Titer] in Serum

10.13

12.49

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.73

12.37

1.1

1.2

—

(3035880) pH of Pleural fluid

4.31

12.22

1.5

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.06

12.14

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

130

3.37

11.95

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.45

11.93

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

146

788

1.93

11.82

4.6

2.8

25.00

25.13

mmol/l

0.17

141

759

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

4.32

11.50

1.2

1.1

661.00

254.71

mg/l

1.65

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.43

11.46

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

5.42

11.36

27.6

25.4

131.50

129.56

ug/l

0.03

(3010421) pH of Blood

351

2.34

11.08

4.8

4.4

7.44

7.42

4.91

315

(3009871) Measles virus Ab [Titer] in Serum

9.27

11.00

1.9

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

21.60

10.68

1.3

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

289

2.45

10.60

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.84

10.49

1.6

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

222

1406

1.67

10.47

1.3

597.50

549.46

titre

0.10

315

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

10.42

1.0

0.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

+∞

10.42

2.0

0.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.46

10.41

1.1

956.90

1766.59

miu/ml

2.12

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

23.51

10.24

2.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

23.51

10.24

2.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

23.51

10.24

2.0

1.0

—

(3017704) Immunofixation for Urine

3.74

10.16

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

444

2.13

10.15

1.5

1.2

—

(40761536) Microorganisms panel - Urine sediment

159

938

1.77

9.70

4.9

4.0

—

(3020393) Adenovirus Ag [Presence] in Stool

15.11

9.51

1.3

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.90

9.42

3.7

3.6

—

(3010937) Rubella virus Ab [Presence] in Serum

+∞

9.38

1.0

0.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.71

9.30

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1094

12176

0.72

9.28

5.0

6.01

6.12

mmol/l

2.01

979

10846

(40768800) Prostate Pathology biopsy report

3.73

9.17

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.30

9.13

1.6

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

104

3.22

8.65

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

106

576

1.90

8.44

2.0

1.2

1573.35

243.33

u/ml

0.77

531

(3008152) Bicarbonate [Moles/volume] in Arterial blood

157

960

1.70

8.43

10.0

6.8

24.82

24.42

mmol/l

0.50

146

920

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

6.73

8.36

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

+∞

8.34

2.3

0.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

11.75

8.07

2.0

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

676

5583

1.35

8.00

5.0

4.2

35.40

99.98

ng/l

1.29

567

4315

(3006184) Hemoglobin [Mass/volume] in Capillary blood

342

2.12

7.93

2.5

2.3

115.58

132.18

g/l

6.53

255

(1761868) Lipid panel - Serum or Plasma

251

3501

0.67

7.88

3.1

3.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

10.85

7.79

2.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

15.09

7.71

5.4

1.3

—

(40768797) Stomach Pathology biopsy report

229

1570

1.53

7.67

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

164

1040

1.64

7.67

3.2

3.6

93.48

95.71

ng/l

0.08

141

876

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

118

2.92

7.61

1.1

1.2

—

(3017732) Neutrophils [#/volume] in Blood

128

762

1.73

7.58

3.3

3.2

5.72

5.84

e9/l

0.04

102

557

(3023323) Follitropin [Units/volume] in Serum or Plasma

108

3.00

7.52

1.8

1.3

27.18

25.51

iu/l

0.10

(3047181) Lactate [Moles/volume] in Blood

449

1.94

7.40

10.6

6.5

1.47

1.33

mmol/l

0.65

404

(3008295) Osmolality of Serum or Plasma

110

2.95

7.29

1.4

271.76

274.58

mosm/kgh2o

0.30

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

15.81

7.23

1.4

1.1

89.36

119.14

—

(3036603) Volume of Urine

3.57

7.15

1.4

1.3

2208.70

1882.17

0.92

(3020876) Protein [Mass/time] in 24 hour Urine

135

2.70

7.01

2.3

1.8

0.88

1.98

g/24h

1.08

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.52

7.00

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.52

7.00

1.2

1.0

—

(3003181) Sodium [Moles/volume] in Urine

239

2.26

7.00

1.6

1.3

64.50

62.63

mmol/l

0.12

192

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

13.83

6.89

1.2

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

378

1.97

6.75

3.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

16.76

6.74

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.17

6.72

1.2

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

144

2.60

6.72

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.41

6.70

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

105

613

1.76

6.68

8.9

5.0

1.54

1.67

0.77

587

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

597

4938

1.32

6.68

2.2

76.50

78.41

nmol/l

0.88

553

4234

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

3.07

6.63

1.0

—

(40757373) Influenza virus identified in Isolate

4.03

6.63

1.6

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

5.91

6.61

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

171

2.43

6.47

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

14.36

6.40

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

11.06

6.30

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

504

1.81

6.29

2.2

2.8

3.83

4.45

pmol/l

6.11

426

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

6.25

1.0

0.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

6.25

1.0

0.0

—

(3049717) Cytology report of Urine Cyto stain

493

1.81

6.14

2.7

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

177

2.35

6.02

1.4

11.28

8.32

u/l

0.78

146

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.26

6.01

1.5

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.56

5.99

1.5

1.2

1.33

1.26

ug/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.89

5.99

3.7

1.2

—

(4212803) Bone marrow aspirate examination

15.06

5.90

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.55

5.89

1.0

2.6

66.69

66.61

mg/l

0.00

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

6.41

5.86

1.2

70.44

46.00

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

11.17

5.79

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

2.81

5.74

1.6

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

2.78

5.64

1.6

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

297

1.99

5.59

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

236

2.11

5.56

1.2

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.51

5.56

1.2

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.23

5.38

1.8

1.4

3.57

4.27

—

(3037121) Protein [Mass/volume] in Urine

439

1.79

5.36

2.6

0.30

0.26

g/l

0.20

146

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.11

5.35

1.5

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

808

7096

1.26

5.31

4.3

3.0

76.13

52.66

u/l

4.89

759

6423

(3039000) Anion gap in Blood

303

1.95

5.30

13.9

7.7

10.28

11.23

mmol/l

1.45

279

(3018572) Chloride [Moles/volume] in Blood

303

1.95

5.30

13.9

7.7

104.22

105.06

mmol/l

0.60

279

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1022

11171

0.79

5.29

4.4

2.03

2.16

mu/l

0.53

922

9943

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.87

5.12

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.77

5.09

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.35

5.08

1.8

1.1

—

(4281824) Cell count and differential, peritoneal fluid

3.42

5.03

1.1

—

(3022145) Colonoscopy Study observation

159

1108

1.48

4.93

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

605

1.64

4.91

10.1

5.1

0.90

0.87

0.33

578

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

250

1.99

4.81

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

103

657

1.60

4.77

1.3

67.20

59.23

au/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.23

4.77

1.0

—

(3020891) Body temperature

610

1.63

4.76

6.2

4.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

388

4711

0.77

4.73

3.4

3.9

12.07

8.60

mg/mmol

0.72

238

3046

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.27

4.32

1.9

2.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.55

4.30

1.3

1.2

68.83

53.56

u/l

0.84

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.97

4.30

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.97

4.30

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

4.02

4.10

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

161

1170

1.42

4.03

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.91

3.99

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

305

1.80

3.96

1.3

1.4

237.54

292.59

ug/g

1.48

188

(40768441) Liver Pathology biopsy report

3.81

3.89

1.8

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.81

3.89

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.29

3.83

1.9

2.5

—

(3007461) Platelets [#/volume] in Blood

1272

13407

0.80

3.81

63.4

21.4

204.05

237.60

e9/l

41.69

1234

12901

(3000963) Hemoglobin [Mass/volume] in Blood

1273

13413

0.80

3.78

63.5

21.6

118.84

135.28

g/l

173.36

1247

13083

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

12.04

3.76

1.0

—

(3035941) MCH [Entitic mass]

1273

13411

0.80

3.76

63.0

21.3

30.53

30.52

0.06

1248

13078

(3026361) Erythrocytes [#/volume] in Blood

1273

13411

0.80

3.76

63.2

21.4

3.97

4.46

e12/l

127.16

1227

12839

(3024731) MCV [Entitic volume]

1273

13410

0.80

3.75

63.1

21.4

92.21

91.75

2.75

1248

13075

(3010813) Leukocytes [#/volume] in Blood

1273

13409

0.80

3.74

63.3

21.4

7.13

6.90

e9/l

0.88

1230

12841

(3051651) Icteric interference index of Serum or Plasma

2.80

3.69

5.0

3.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

1273

13403

0.80

3.68

63.7

21.6

35.77

39.87

83.82

1184

12185

(3015736) pH of Urine

564

4910

1.22

3.63

4.0

3.5

5.43

5.79

0.46

199

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

385

0.38

3.61

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.52

3.60

1.2

1.1

—

(40768793) Breast Pathology biopsy report

2.96

3.57

1.5

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

383

4526

0.80

3.54

2.8

3.2

6.84

7.43

mmol/l

2.33

309

3756

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

5.32

3.51

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.18

3.50

1.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

128

2.13

3.30

1.1

1.2

—

57.84

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1158

0.66

3.28

1.4

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

377

3179

1.24

3.25

1.8

1193.63

1166.16

nmol/l

0.21

300

2376

(3044007) Cell count panel - Peritoneal fluid

4.19

3.19

1.1

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

130

2.09

3.19

1.2

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

237

1.79

3.15

1.3

1.1

49.55

23.37

u/l

0.66

207

(3012516) Albumin [Mass/volume] in Urine

380

4440

0.81

3.09

3.4

3.3

2028.84

141.63

mg/l

3.24

243

2898

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

217

1.82

3.07

1.1

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.52

3.05

1.0

1.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

7.52

3.05

3.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.02

3.05

1.3

1.2

15.23

16.55

u/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.02

3.05

1.0

1.3

—

(3014891) Appearance of Pleural fluid

4.30

2.99

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

190

1.86

2.98

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

10.02

2.98

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

586

0.55

2.92

1.7

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

676

6081

1.18

2.92

4.5

3.8

0.00

0.01

estimate

1.15

183

1120

(40761995) Spermatozoa Progressive [#/volume] in Semen

6.68

2.87

1.5

3.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

6.68

2.87

3.0

6.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.46

2.79

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

202

1.80

2.78

1.3

1.2

42.76

58.78

u/ml

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

188

1486

1.30

2.78

3.6

3.2

289.79

249.01

ng/l

0.67

176

1368

(3041096) Erythrocytes [Presence] in Urine by Automated

362

3089

1.22

2.76

4.6

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

100

723

1.41

2.66

2.3

2.5

—

(21494755) Public health laboratory ask at order entry panel

493

0.54

2.65

1.4

—

(3019977) pH of Arterial blood

2.22

2.64

6.5

2.2

7.46

7.42

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

645

5820

1.17

2.61

3.1

2.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.01

2.57

1.3

—

(3024928) Oxygen saturation in Venous blood

292

1.63

2.55

2.2

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

668

6055

1.17

2.54

5.9

5.1

0.00

estimate

-0.00

174

1013

(3007566) Smooth muscle Ab [Titer] in Serum

285

1.63

2.53

1.1

78.33

88.42

titre

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.28

2.51

1.1

1.6

16.05

14.68

umol/l

0.34

(3033799) Differential panel - Peritoneal fluid

3.47

2.48

1.1

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

675

6134

1.17

2.47

4.5

3.8

0.00

estimate

0.50

173

982

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.82

2.46

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

204

1.73

2.42

2.7

3.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.35

2.39

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.51

2.36

1.5

1.1

65.46

19.68

u/l

1.41

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.23

2.30

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

385

3361

1.19

2.28

5.1

4.1

0.00

estimate

0.50

159

964

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.95

2.28

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

193

1.72

2.27

3.5

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.87

2.21

3.6

2.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

395

1.48

2.16

4.2

4.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.01

2.15

7.2

1.6

—

(3003338) MCHC [Mass/volume]

937

9952

0.87

2.14

55.3

19.6

330.50

332.14

g/l

6.12

922

9829

(40761535) Cells panel - Urine sediment

149

1186

1.28

2.13

3.9

3.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

445

0.58

2.09

1.5

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

365

1.50

2.09

4.6

2.9

1.56

1.69

mmol/l

0.54

352

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1082

0.73

2.09

1.6

1.7

1.60

1.58

0.12

913

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

184

1509

1.25

2.06

2.0

2.5

5.27

7.68

ug/l

1.32

153

1299

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

110

1.92

2.06

1.2

1.5

—

181.25

—

(3038515) Glucose [Moles/volume] in Venous blood

342

1.51

2.06

4.8

3.0

6.82

7.72

mmol/l

2.22

330

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

494

4440

1.16

2.02

2.0

2.2

159.28

238.92

u/l

1.20

470

4133

(3034770) Mitochondria Ab [Titer] in Serum

295

1.54

2.01

1.1

—

1256.25

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.82

2.00

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.20

1.94

1.9

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.56

1.94

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

195

1.65

1.93

9.8

7.1

7.46

7.68

mmol/l

0.15

160

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

397

0.57

1.93

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.25

1.91

1.5

1.1

152.38

94.39

u/l

0.59

(4146454) Self-monitoring of blood glucose

173

0.40

1.90

2.9

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

121

1.83

1.88

4.4

3.2

—

(3013512) EKG study

453

4067

1.15

1.87

5.5

4.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

840

8934

0.88

1.83

4.1

3.6

14.98

15.07

pmol/l

0.39

759

7914

(3035320) C reactive protein [Mass/volume] in Body fluid

1.96

1.80

1.8

2.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

393

3501

1.16

1.80

1.7

1.6

17.30

19.88

nmol/l

3.61

353

2916

(3039443) Prostate specific Ag panel - Serum or Plasma

232

0.47

1.76

2.5

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.23

1.74

1.1

124.63

96.55

u/l

0.42

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.23

1.74

1.1

52.31

30.04

u/l

0.45

(4200892) Spirometry reversibility

904

0.74

1.64

1.4

—

(3001729) Color of Synovial fluid

3.58

1.61

1.4

1.3

—

(40768446) Kidney Pathology biopsy report

2.51

1.59

1.4

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

140

1687

0.81

1.55

3.7

5.0

29.80

33.15

4.22

109

1098

(40761511) CBC panel - Blood by Automated count

1206

12487

0.88

1.53

35.4

14.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1261

12178

1.13

1.53

49.0

14.8

30.18

26.10

mg/l

4.62

1204

9658

(4034850) Laboratory test

464

0.66

1.49

16.8

10.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

513

4709

1.13

1.49

4.9

4.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

147

1.64

1.47

1.2

0.75

0.64

nmol/l

0.34

138

(3023103) Potassium [Moles/volume] in Serum or Plasma

1263

13030

0.88

1.47

48.5

18.3

4.00

4.01

mmol/l

1.11

1232

12590

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

1.70

1.47

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.38

1.45

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.13

1.44

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

1.66

1.42

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.78

1.39

2.0

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

464

5046

0.89

1.37

3.9

3.8

21.50

24.42

3.51

221

2498

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

121

1001

1.22

1.32

3.2

2.4

54.23

61.38

ml/min/173m2

1.16

406

(3019550) Sodium [Moles/volume] in Serum or Plasma

1263

13002

0.89

1.31

47.9

18.2

138.80

139.73

mmol/l

24.51

1235

12583

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.94

1.27

1.2

1.5

8.43

9.38

umol/l

—

(3016038) Potassium [Moles/volume] in Urine

100

1.71

1.23

1.3

1.2

29.12

35.21

mmol/l

0.88

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1256

12918

0.90

1.22

27.1

9.3

27.10

25.39

u/l

1.83

1234

12262

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

1.61

1.17

1.2

—

nmol/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

291

1.38

1.16

1.3

1.2

2.98

5.39

u/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.3

—

138.34

—

(3048689) Calprotectin [Mass/mass] in Stool

132

1120

1.19

1.14

2.3

2.1

200.38

179.73

ug/g

0.28

108

866

(40762814) Titanium [Mass/volume] in Blood

0.00

1.14

0.0

2.4

—

2.86

—

(3004451) EKG impression Narrative

1.76

1.06

1.7

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

129

1.56

1.05

1.7

2.0

0.63

1.90

u/field

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.92

1.02

10.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.92

1.02

10.7

2.6

—

(3016750) Collection duration of Urine

1.69

1.01

2.1

1.9

533.67

485.35

min

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.69

1.01

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

310

0.67

1.01

2.0

1.7

54.62

43.82

nmol/l

0.68

291

(3026470) Cobalt [Mass/volume] in Blood

110

0.45

1.00

2.4

2.0

2.80

3.30

ug/l

—

100

(3047007) Chlamydophila sp Ab [Presence] in Serum

115

1.57

0.99

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.72

0.99

2.4

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.97

0.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

587

6212

0.92

0.97

4.3

3.9

3.42

2.15

ug/l

1.55

502

5512

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

2.5

—

149.92

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

0.96

0.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

456

0.74

0.96

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

328

0.70

0.94

3.6

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

197

0.61

0.94

1.1

1.2

—

(1002224) Polysomnography panel

316

0.69

0.93

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

328

3016

1.11

0.92

3.9

3.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.67

0.91

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.67

0.91

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.67

0.91

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

135

1.49

0.89

1.0

1.1

1.74

1.56

g/l

0.97

119

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

846

0.82

0.88

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.82

0.86

1.6

1.4

30.68

36.45

u/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

239

0.67

0.85

1.4

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.63

0.84

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.63

0.84

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.63

0.84

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.71

0.80

1.1

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.09

0.74

1.0

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

2.09

0.74

1.4

1.2

92.04

81.21

mu/l

—

(3016879) Cocaine [Presence] in Urine

132

0.60

0.73

1.0

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

345

0.75

0.73

1.1

—

(3027944) Amphetamines [Presence] in Urine

136

0.59

0.73

1.0

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

100

1.50

0.73

1.1

1.0

4.48

2.43

u/ml

—

(3042733) HLA Ab [Presence] in Serum

2.00

0.72

2.6

3.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.55

0.72

1.2

1.8

113.23

97.05

umol/l

0.21

(3027456) Digoxin [Moles/volume] in Serum or Plasma

400

1.23

0.70

2.9

3.2

0.95

0.85

nmol/l

0.69

304

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.85

0.68

1.4

1.1

210.00

236.19

pmol/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.60

0.68

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

199

2166

0.91

0.63

1.2

2.33

1.61

u/ml

0.35

550

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

199

1.31

0.62

1.3

1.8

9.82

4.41

iu/l

—

(3028300) Cannabinoids [Presence] in Urine

137

0.66

0.60

1.0

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.60

0.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.59

0.0

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

113

0.62

0.58

1.0

1.7

—

(3017569) Oxygen content in Arterial blood

1.46

0.58

2.2

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

365

1.21

0.57

1.6

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1111

11340

0.94

0.56

41.3

13.8

74.04

73.05

ml/min/173m2

0.75

1012

9133

(3000492) Spirometry study

108

965

1.13

0.56

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.62

0.55

2.2

2.32

7.26

nmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.58

0.54

1.5

1.3

16.80

9.37

ug/l

—

(3011288) Drugs identified in Urine by Screen method

0.61

0.52

1.0

2.7

—

(3000764) Benzodiazepines [Presence] in Urine

135

0.66

0.51

1.0

1.7

—

(3004775) Volume in Urine collected for unspecified duration

126

1.35

0.51

1.9

2.4

741.38

618.00

—

(3027008) Opiates [Presence] in Urine

136

0.66

0.51

1.0

1.7

—

(3044889) 12 lead EKG panel

912

8902

1.05

0.49

5.2

4.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

160

1732

0.92

0.48

1.2

8.17

12.74

u/ml

0.66

615

(3019150) Specific gravity of Urine by Refractometry

276

2923

0.93

0.48

5.1

4.1

1.02

kg/l

0.01

448

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.47

0.47

2.7

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

155

1.29

0.46

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

155

1.29

0.46

1.8

1.5

—

(3012565) Volume of 24 hour Urine

1.46

0.46

3.0

2.1

1627.14

1995.12

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.40

0.45

1.3

5.90

6.61

mmol/l

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.61

0.43

1.2

2.1

1.28

1.21

mmol/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

122

1.31

0.42

1.3

1.2

2.67

6.67

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

618

5993

1.05

0.42

2.1

86.34

92.57

pmol/l

2.59

359

3115

(3029075) Extractable nuclear Ab panel - Serum

1.52

0.41

1.2

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

15.86

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

7.96

—

(3045414) Leukocytes [Presence] in Urine

497

0.86

0.40

2.3

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

331

3458

0.95

0.38

2.8

2.7

0.77

0.75

ug/l

0.14

223

2420

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

388

0.85

0.38

1.6

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

172

1835

0.93

0.38

15.8

7.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

726

0.89

0.38

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

1.35

0.38

2.4

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

458

1.14

0.37

1.5

1.3

—

(3000330) Specific gravity of Urine by Test strip

726

1.11

0.36

4.1

3.7

—

(3011648) Oxygen content in Venous blood

1.32

0.35

1.5

2.0

9.55

10.85

0.39

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

405

0.86

0.35

2.2

121.73

87.33

ug/min

0.20

240

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

167

0.78

0.34

1.2

1.4

43.51

66.27

—

105

(3017446) Testosterone [Moles/volume] in Serum or Plasma

778

1.10

0.33

2.4

2.1

13.24

14.76

nmol/l

1.23

678

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.31

0.30

1.0

1.2

9.52

9.30

mmol/l

0.09

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

364

1.13

0.28

1.8

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

140

0.78

0.28

2.5

3.1

4.97

29.45

mg/l

—

113

(36660697) Celiac disease serology panel - Serum

771

0.92

0.27

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

0.78

0.27

1.1

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.19

0.26

1.0

1.1

107.25

141.24

nmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

331

3210

1.04

0.24

1.7

530.46

28930508.18

pmol/l

2.60

274

2589

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

125

0.80

0.23

1.2

7.96

8.11

mmol/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

358

0.89

0.22

2.2

1.6

10128.59

14157.59

e6/l

0.57

265

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.76

0.22

1.4

1.1

83.71

94.72

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

369.18

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.7

—

22.62

—

(3044941) Cell count panel - Synovial fluid

241

0.87

0.21

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

156

0.83

0.21

1.7

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

173

1.16

0.21

2.0

2.5

26.29

21.48

mg/l

—

(3021788) Differential panel - Synovial fluid

251

0.87

0.21

1.4

1.5

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

127

1.18

0.19

1.3

1.2

1.50

4.02

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

—

14.61

—

(3005570) Glucose [Moles/volume] in Urine

147

1.16

0.18

1.5

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

121

0.83

0.18

1.3

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

173

1790

0.96

0.17

1.2

1.3

38.64

40.88

iu/ml

0.06

543

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.73

0.17

1.8

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

1023

10148

1.02

0.14

51.5

17.1

15.42

15.34

0.26

1014

9884

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

266

1.09

0.14

1.6

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

108

0.83

0.13

1.1

—

73.40

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

109

0.82

0.13

1.1

—

69.83

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1.18

0.12

1.0

298.40

293.25

mg/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

328

1.07

0.11

3.8

3.5

35.75

29.40

mg/l

0.61

223

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.08

0.08

5.7

4.5

13.81

13.24

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.82

0.07

1.7

1.4

0.93

g/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.07

0.07

1.0

1.3

110.50

176.61

pmol/l

—

(3008898) HLA-B27 [Presence]

245

0.94

0.07

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.82

0.07

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

0.87

0.06

5.5

13.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

159

1.07

0.05

1.0

—

(3045424) Erythrocytes [Presence] in Urine

169

1.07

0.05

1.8

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

160

0.94

0.04

1.1

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

517

1.03

0.04

1.1

1.2

103.35

99.57

iu/ml

0.03

203

(3022621) pH of Urine by Test strip

890

0.99

0.02

3.3

3.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

423

0.99

0.00

1.1

—

299.43

titre

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.92

0.00

2.0

1.7

13.43

17.18

nmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

10.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.91

-0.00

2.8

2.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

1.01

-0.00

1.2

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

0.99

-0.00

1.1

1.4

1.25

1.04

nmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.96

-0.00

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

1.8

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.5

—

1112.67

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.94

-0.00

1.1

—

4.83

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_NONHODGKIN – Non-Hodgkin lymphoma, all

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-Hodgkin lymphoma, all

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-Hodgkin lymphoma, all (C3_NONHODGKIN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints